MedPage Today on MSN
Practice-Influencing Results in Oligometastatic Prostate Cancer
Median progression-free survival (PFS) increased from 7.4 months with stereotactic body radiotherapy (SBRT) to 17.6 months ...
September is Prostate Cancer Awareness Month, and when many men choose to get check-ups. Though the month is nearly over, ...
Patients with prostate cancer can position themselves to receive the best care possible by being seen by a multidisciplinary ...
For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...
After revealing his prostate cancer diagnosis, Montell Jordan says early detection saved his life, and he hopes his new tour will encourage men to get screened.
BAMF Health in Grand Rapids is offering an alternative treatment for prostate cancer that doesn't involve chemotherapy.
MILLWALL keeper Lukas Jensen received bombshell news from his dad Brian that he had been diagnosed with prostate cancer. It ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...
News-Medical.Net on MSN
Gene expression test identifies prostate cancer patients who benefit from hormone therapy
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
News-Medical.Net on MSN
Combining radiopharmaceuticals with targeted radiation improves progression-free survival in prostate cancer patients
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...
La'Dale Robinson was living a full life as a single father, chef, and business owner when a routine checkup changed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results